Keyword      Search in       

Contact
Imprint
Site Map

RSS Feed News. Your shopping cart.

Google gadget.

GMP News
12/08/2010
 

Shared Audit at Pfizer's Manufacturing Site in the US

  
The "APIC Audit Programme" is a third-party audit programme for auditing API manufacturers, distributors and API contract manufacturers and/or contract laboratories. It is the aim of the APIC Audit Programme to offer an independent GMP compliance audit of API manufacturers and/or distributors, including organisation, conduct and evaluation of the audit.

On 15-16 March 2010, a regular re-audit was performed at Pfizer Global Manufacturing in Kalamazoo, USA. A re-audit is recommended every 3 years in order to check the facility for on-going GMP compliance. Two certified APIC Auditors performed the audit during the course of two days.

An 'APIC Audit' within the framework of the APIC Audit Programme can be initiated by one or more QPs of one or various manufacturing authorisation holders in order to get independent information about the GMP compliance status of the API supplier. On 19 and 20 November 2007, a first APIC Audit was performed at Pfizer Global Manufacturing in Kalamazoo on behalf of 9 customers (Qualified Persons). More than 20 companies have purchased the audit report since. The audit report for the 2010 re-audit is now available. More information is available here.

Source: API Compliance Institute press release: www.api-compliance.org

The latest update on the APIC Audit Programme will be presented at two forthcoming major events: the European API Conference in Barcelona and the QP Forum Auditing Conference in London.

Related GMP News
08/02/2012EXCiPACT - A new Certification Scheme for Excipients has been launched
01/02/2012Significant Administrative Changes in the New Revision of the Guideline on the ASMF Procedure
25/01/2012Extension of Directive 2003/94/EC to GMP for APIs - EC Commission publishes Concept Paper for Comment
18/01/2012Inadequate Validation of Analytical Methods remains permanent Topic in Warning Letters to API Manufacturers
12/01/2012GMP non-Compliance causes further CEP Suspensions